Abstract
Translocation of phosphatidylserine (PS) to the outer leaflet of the cellular membrane seems to be a key step in apoptosis and cell activation. In this paper, the production and characterization of a monoclonal antibody designated as Mab 1H6 is described which does not show cross reactivity with others anionic phospholipids. It is demonstrated that Mab1H6 can recognize externalized PS at early stages after the induction of apoptosis shown by both flow cytometry and immunofluorescence. Our results show that translocation of PS can be detected as early as 5 min by immunofluorescence and 10 min by flow cytometry after the treatment of cells and a specific dynamics is observed concerning the location and distribution of the staining. These data prove that antibody Mab 1H6 can be used as a specific probe for detection of PS translocation.
Similar content being viewed by others
References
Deavux PF, Zachowski A. Maintenance and consequences of membrane phospholipid asymmetry. Chem Phys Lipid 1994; 73: 107–120.
Adler R, Ng A-K, Rote NS. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma JAR. Biol Reprod 1995; 53: 905–910.
Rote NS, Ng A-K, Dostal-Johnson DA, Nicholson SL, Siekman R. Immunologic detection of phosphatidylserine externalization during thrombin-induced platelet activation. Clin Immunol Immunopathol 1993; 66: 193–200.
Cocca BA, Seal SN, D’Agnillo P, et al. Structural basis for autoantibody recognition of phosphatidylserine-b2 glycoprotein I and apoptotic cells. PNAS 2001; 98: 13826–13831.
Eguchi K. Apoptosis in autoimmune diseases. Intern Med 2001; 40: 275–284.
Umeda M, Igarashi K, Nam SK, Inoue K. Effective production of monoclonal antibodies against phosphatidylserine: Stereo-specific recognition of phosphatidylserine by monoclonal antibody. Journal Immunol 1989; 143: 2273– 2279.
Pittoni V, Ravirajan CT, Donohue S, Machin SJ, Lydyard PM, Isemberg DA. Human monoclonal anti-phospholipid antibodies selectively bind to membrane phospholipid and b2-glycoprotein I (b2GPI) on apoptotic cells. Clin Exp Immunol 2000; 119: 533–543.
Devaux PF. Protein involvement in transmembrane lipid asymmetry. Annu Rev Biophys Biomol Struct 1992; 21: 417– 439.
Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem 1997; 272: 18240–18244.
Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990; 265: 4923– 4928.
Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 2002; 62: 6132–6140.
Mandinov L, Mandinova A, Kyurkchiev S, et al. Copper chelation represses the vascular response to injury. Proc Natl Acad Sci USA 2003; 100: 6700–6705.
Gong J, Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994; 218(2): 314–319.
Ran S, Thorpe PE. Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J Radiation Oncology Biol Phys 2002; 54(5): 1479–1484.
Utz PJ, Gensler TJ, Anderson P. Death, autoantigen modifications, and tolerance. Arthritis Research 2000; 2: 101–114.
Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptotic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998; V7,N2,P113-8,D.
Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: Relations with desease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999, 58: 309–314.
Rose LM, Latchman DS, Isenberg DA. Apoptosis in peripheral lymphocytes in systemic lupus erythematosis: A review. Br J Rheumatol 1997, 36: 158–163.
Schtoit AJ, Madsen J, Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem 1985; 260: 5131.
Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophager. J Immunol 1992; 148: 2207–2216.
Vogt E, Ng AK, Rote NS. A model for the antiphospholipid antibody syndrome: Monoclonal antiphoshatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996; 174; 2: 700–707.
Le DT, Rapaport SI, Rao VM. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activatin of factor X on fibroblast monolayers after their exposure to N-ethylmaleimide. Tromb Haemost 1994; 72: 848–855.
Gargalovic P, Doryl L. Cellular apoptosis is associated with increased calveolin-1 expression in macrophages. J Lipid Res 2003; 44: 1622–1632.
Author information
Authors and Affiliations
Corresponding author
Additional information
M.M. and D.K. contributed equally to this work
Rights and permissions
About this article
Cite this article
Mourdjeva, M., Kyurkchiev, D., Mandinova, A. et al. Dynamics of membrane translocation of phosphatidylserine during apoptosis detected by a monoclonal antibody. Apoptosis 10, 209–217 (2005). https://doi.org/10.1007/s10495-005-6076-5
Issue Date:
DOI: https://doi.org/10.1007/s10495-005-6076-5